Current Medical and Surgical Treatments for Benign Prostatic Hyperplasia, An Issue of Urologic Clinics of North America
- 1st Edition, Volume 52-4 - November 28, 2025
- Latest edition
- Editor: Steven A. Kaplan
- Language: English
In this issue of Urologic Clinics of North America, guest editor Dr. Steven A. Kaplan brings his considerable expertise to the topic of Current Medical and Surgical Treatment… Read more
Purchase options
In this issue of Urologic Clinics of North America, guest editor Dr. Steven A. Kaplan brings his considerable expertise to the topic of Current Medical and Surgical Treatments for Benign Prostatic Hyperplasia. Top experts explore evidence-based approaches, novel techniques, and outcomes that provide a holistic understanding of BPH management, sharing their clinical experience while also looking forward at how genetics and AI can impact BPH patient outcomes.
- Contains 14 relevant, practice-oriented topics, including do genetics predict BPH?; AI in BPH; what’s new in the AUA guidelines for BPH?; UroLift, Rezum, and iTIND for BPH; medical therapy for BPH: benefits and harms; and much more
- Provides in-depth clinical reviews on medical and surgical treatments for benign prostatic hyperplasia, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Urology
Do Genetics Predict Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia?
Patient Work-Up in the Modern Workplace: Role of Remote and Non-Invasive Diagnostics
Improving Patient Selection for BPH Medical and Surgical Therapy Through a Deeper Understanding of Prostate Cellular and Molecular Biology
Artificial Intelligence in Benign Prostatic Hyperplasia
Laser Enucleation Therapy for Benign Prostatic Hyperplasia
Making Waves: An Update on Aquablation
UroLift, Rezum, �and iTind for Benign Prostatic Hyperplasia
Balloons in Benign Prostatic Hyperplasia: Will They Float? A Comprehensive Review of Prostatic Balloon Prostatoplasty
Novel Stent-like Devices for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Updates on Prostate Arterial Embolization
Nocturia in Men: Is the Prostate Really to Blame?
Medical Therapy for Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
Review of Current Guidelines and Innovations in Benign Prostatic Hyperplasia Evaluation and Management
Benign Prostatic Hyperplasia Procedures in Patients with Prostate Cancer: What Do We Know?
Patient Work-Up in the Modern Workplace: Role of Remote and Non-Invasive Diagnostics
Improving Patient Selection for BPH Medical and Surgical Therapy Through a Deeper Understanding of Prostate Cellular and Molecular Biology
Artificial Intelligence in Benign Prostatic Hyperplasia
Laser Enucleation Therapy for Benign Prostatic Hyperplasia
Making Waves: An Update on Aquablation
UroLift, Rezum, �and iTind for Benign Prostatic Hyperplasia
Balloons in Benign Prostatic Hyperplasia: Will They Float? A Comprehensive Review of Prostatic Balloon Prostatoplasty
Novel Stent-like Devices for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Updates on Prostate Arterial Embolization
Nocturia in Men: Is the Prostate Really to Blame?
Medical Therapy for Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
Review of Current Guidelines and Innovations in Benign Prostatic Hyperplasia Evaluation and Management
Benign Prostatic Hyperplasia Procedures in Patients with Prostate Cancer: What Do We Know?
- Edition: 1
- Latest edition
- Volume: 52-4
- Published: November 28, 2025
- Language: English
SK
Steven A. Kaplan
Affiliations and expertise
Professor of Urology, Chair of Research, American Urological Association, Icahn School of Medicine at Mount Sinai, Director, Benign Urologic Diseases and The Men's Health Program, Mount Sinai Health System, USA